Neonatal Diseases Nutritional, Metabolic, Endocrine Paediatrics Cardiology
Conditions
Interventions
L carnitine supplementation
Sponsors
Shahinaz gamal
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Age: childern under the age of 18 years. 2) Gender : both sexes will be included . 3) Full term. 4) Malnourished patients with controlled heart failure due to congenital heart disease according to NYHA class I and II (New York Heart Association, 1994) and Ross class I and II (Ross ., 2012).
Exclusion criteria
Exclusion criteria: 1) Patients with chromosomal abnormalities and other congenital malformations than cardiac anomalies or other comorbid diseases affecting the growth or the nutritional status of the children 2) Patients with complex cyanotic congenital heart disease such as Truncus arteriosus, TGA (Transposition of great arteries). 3) Patients born prematurely (<36 weeks gestation) or low birth weight 4) Patients with heart failure secondary to diseases other than CHD such as dilated cardiomyopathy, Hypertrophic cardiomyopathy. 5) Uncontrolled patients with severe disease requiring admission at the time of assessment 6) Postoperative patients. 7) Refusal to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of L-Carnitine supplementation on the nutritional status, improvement of the cardiac function and frequency of hospitalization in malnourished children with controlled heart failure secondary to CHD .;Effect of L-Carnitine supplementation on the nutritional status, improvement of the cardiac function and frequency of hospitalization in malnourished children with controlled heart failure secondary to CHD | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of malnutrition in children with controlled heart failure 2ndry to CHD ;Correlation between the type of CHD and presence of HF with the severity of malnutrition | — |
Countries
Egypt
Contacts
Public ContactShahinaz Mansour
Specialist of pediatrics
Outcome results
None listed